These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37481138)

  • 1. The molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma.
    Corallo D; Dalla Vecchia M; Lazic D; Taschner-Mandl S; Biffi A; Aveic S
    Biochem Pharmacol; 2023 Sep; 215():115696. PubMed ID: 37481138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy.
    Vrenken KS; Vervoort BMT; van Ingen Schenau DS; Derks YHW; van Emst L; Grytsenko PG; Middelbeek JAJ; van Leeuwen FN
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165644. PubMed ID: 31862304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.
    Middelbeek J; Visser D; Henneman L; Kamermans A; Kuipers AJ; Hoogerbrugge PM; Jalink K; van Leeuwen FN
    Oncotarget; 2015 Apr; 6(11):8760-76. PubMed ID: 25797249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of invasion and metastasis in human neuroblastoma.
    Ara T; DeClerck YA
    Cancer Metastasis Rev; 2006 Dec; 25(4):645-57. PubMed ID: 17160711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
    Tomolonis JA; Agarwal S; Shohet JM
    Cell Tissue Res; 2018 May; 372(2):245-262. PubMed ID: 29222693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell adhesion molecules as targets for therapy of neuroblastoma.
    Yoon KJ; Danks MK
    Cancer Biol Ther; 2009 Feb; 8(4):306-11. PubMed ID: 19197150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of new orthotopic and metastatic neuroblastoma models.
    Daudigeos-Dubus E; LE Dret L; Rouffiac V; Bawa O; Leguerney I; Opolon P; Vassal G; Geoerger B
    In Vivo; 2014; 28(4):425-34. PubMed ID: 24982206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.
    Tan CY; Chang CL
    Lab Invest; 2018 Feb; 98(2):219-227. PubMed ID: 28991262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A NOTCH3 transcriptional module induces cell motility in neuroblastoma.
    van Nes J; Chan A; van Groningen T; van Sluis P; Koster J; Versteeg R
    Clin Cancer Res; 2013 Jul; 19(13):3485-94. PubMed ID: 23649002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium phosphate scaffolds with defined interconnecting channel structure provide a mimetic 3D niche for bone marrow metastasized tumor cell growth.
    Aveic S; Davtalab R; Vogt M; Weber M; Buttler P; Tonini GP; Fischer H
    Acta Biomater; 2019 Apr; 88():527-539. PubMed ID: 30797105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TRPM7 interactome defines a cytoskeletal complex linked to neuroblastoma progression.
    Middelbeek J; Vrenken K; Visser D; Lasonder E; Koster J; Jalink K; Clark K; van Leeuwen FN
    Eur J Cell Biol; 2016 Nov; 95(11):465-474. PubMed ID: 27402209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
    Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
    Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia in the Initiation and Progression of Neuroblastoma Tumours.
    Huertas-Castaño C; Gómez-Muñoz MA; Pardal R; Vega FM
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical models of pediatric solid tumors (neuroblastoma) and their use in drug discovery.
    Patterson DM; Shohet JM; Kim ES
    Curr Protoc Pharmacol; 2011 Mar; Chapter 14():Unit 14.17. PubMed ID: 21935903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Is Aneuploidy Associated with Favorable Outcome in Neuroblastoma?
    Tonini GP
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration.
    Fife CM; Sagnella SM; Teo WS; Po'uha ST; Byrne FL; Yeap YY; Ng DC; Davis TP; McCarroll JA; Kavallaris M
    Oncogene; 2017 Jan; 36(4):501-511. PubMed ID: 27321182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
    Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
    Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature.
    Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickström M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish as a model to study neuroblastoma development.
    Casey MJ; Stewart RA
    Cell Tissue Res; 2018 May; 372(2):223-232. PubMed ID: 29027617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.
    Fabian J; Opitz D; Althoff K; Lodrini M; Hero B; Volland R; Beckers A; de Preter K; Decock A; Patil N; Abba M; Kopp-Schneider A; Astrahantseff K; Wünschel J; Pfeil S; Ercu M; Künkele A; Hu J; Thole T; Schweizer L; Mechtersheimer G; Carter D; Cheung BB; Popanda O; von Deimling A; Koster J; Versteeg R; Schwab M; Marshall GM; Speleman F; Erb U; Zoeller M; Allgayer H; Simon T; Fischer M; Kulozik AE; Eggert A; Witt O; Schulte JH; Deubzer HE
    Oncotarget; 2016 Oct; 7(41):66344-66359. PubMed ID: 27572323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.